The Advisory Council on the Misuse of Drugs is expected to propose the reclassification of Ecstasy (MDMA). At present, ecstasy is categorized as a Class A drug, alongside heroin and cocaine. The recommendation to downgrade the drug to Class B appears to be based on a principle of “relative harm.”   Such reclassification may be … Continue reading »